Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mammary Neoplasms, Experimental | 5 | 2024 | 507 | 0.810 |
Why?
|
Losartan | 3 | 2021 | 265 | 0.770 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 3 | 2021 | 431 | 0.720 |
Why?
|
Radiation Tolerance | 5 | 2017 | 479 | 0.680 |
Why?
|
Neoplasm Transplantation | 11 | 2014 | 2013 | 0.530 |
Why?
|
Receptors, CXCR4 | 5 | 2019 | 727 | 0.450 |
Why?
|
Phenylurea Compounds | 4 | 2020 | 527 | 0.440 |
Why?
|
Carcinoma, Hepatocellular | 7 | 2022 | 2294 | 0.440 |
Why?
|
Glioblastoma | 5 | 2021 | 3480 | 0.400 |
Why?
|
Rodent Diseases | 1 | 2011 | 53 | 0.380 |
Why?
|
Mice, SCID | 6 | 2016 | 2625 | 0.370 |
Why?
|
Niacinamide | 3 | 2017 | 413 | 0.320 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 4 | 2019 | 544 | 0.320 |
Why?
|
Liver Neoplasms | 7 | 2022 | 4314 | 0.320 |
Why?
|
Mice | 52 | 2024 | 81066 | 0.320 |
Why?
|
Neoplasms, Experimental | 3 | 2019 | 1228 | 0.320 |
Why?
|
Tumor Cells, Cultured | 10 | 2021 | 6128 | 0.320 |
Why?
|
Transplantation, Heterologous | 10 | 2015 | 2378 | 0.310 |
Why?
|
Neovascularization, Pathologic | 6 | 2019 | 2638 | 0.300 |
Why?
|
Liver Neoplasms, Experimental | 2 | 2021 | 189 | 0.300 |
Why?
|
Mice, Nude | 13 | 2019 | 3600 | 0.270 |
Why?
|
Tumor Microenvironment | 9 | 2024 | 3839 | 0.270 |
Why?
|
Animals | 60 | 2024 | 167718 | 0.260 |
Why?
|
Receptor, erbB-2 | 3 | 2024 | 2552 | 0.260 |
Why?
|
Cell Line, Tumor | 17 | 2024 | 16881 | 0.260 |
Why?
|
Stress, Mechanical | 3 | 2020 | 1664 | 0.250 |
Why?
|
Immunotherapy | 5 | 2021 | 4641 | 0.250 |
Why?
|
Brain Neoplasms | 5 | 2020 | 8981 | 0.240 |
Why?
|
Whole-Body Irradiation | 2 | 2014 | 433 | 0.230 |
Why?
|
Disulfiram | 1 | 2024 | 63 | 0.230 |
Why?
|
Neurofibromatosis 2 | 2 | 2019 | 385 | 0.220 |
Why?
|
Radiotherapy Dosage | 6 | 2023 | 2894 | 0.220 |
Why?
|
Neuroma, Acoustic | 2 | 2019 | 459 | 0.220 |
Why?
|
Disease Models, Animal | 13 | 2023 | 18114 | 0.210 |
Why?
|
Sarcoma | 5 | 1996 | 1784 | 0.210 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2022 | 3480 | 0.200 |
Why?
|
Breast Neoplasms | 9 | 2024 | 20992 | 0.200 |
Why?
|
Copper | 1 | 2024 | 366 | 0.190 |
Why?
|
MicroRNAs | 1 | 2017 | 3780 | 0.190 |
Why?
|
Glucocorticoid-Induced TNFR-Related Protein | 1 | 2021 | 39 | 0.190 |
Why?
|
Sciatica | 1 | 2021 | 97 | 0.180 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2021 | 5253 | 0.180 |
Why?
|
Neoplasms, Radiation-Induced | 2 | 2014 | 547 | 0.170 |
Why?
|
Green Fluorescent Proteins | 1 | 2005 | 2056 | 0.170 |
Why?
|
Chemokine CXCL10 | 1 | 2020 | 316 | 0.170 |
Why?
|
Osteosarcoma | 1 | 2005 | 896 | 0.160 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2023 | 3069 | 0.160 |
Why?
|
Angiogenesis Inhibitors | 3 | 2022 | 2047 | 0.160 |
Why?
|
Cerebellopontine Angle | 1 | 2019 | 53 | 0.160 |
Why?
|
Cholangiocarcinoma | 1 | 2024 | 551 | 0.160 |
Why?
|
Mice, Inbred BALB C | 2 | 2024 | 6204 | 0.150 |
Why?
|
Receptor, Angiotensin, Type 1 | 2 | 2016 | 148 | 0.150 |
Why?
|
Cisplatin | 1 | 2024 | 1647 | 0.150 |
Why?
|
Lung Neoplasms | 2 | 2021 | 13268 | 0.150 |
Why?
|
Protons | 1 | 2023 | 1112 | 0.150 |
Why?
|
Mice, Inbred C3H | 5 | 2015 | 915 | 0.140 |
Why?
|
Cancer Vaccines | 1 | 2024 | 1046 | 0.140 |
Why?
|
Adenocarcinoma | 4 | 2024 | 6323 | 0.130 |
Why?
|
Heparan Sulfate Proteoglycans | 1 | 2016 | 112 | 0.130 |
Why?
|
Elasticity | 1 | 2018 | 652 | 0.130 |
Why?
|
Implants, Experimental | 1 | 2016 | 98 | 0.130 |
Why?
|
Receptors, Estrogen | 1 | 2024 | 2208 | 0.130 |
Why?
|
Th1 Cells | 1 | 2021 | 1031 | 0.130 |
Why?
|
Nasopharyngeal Neoplasms | 4 | 1991 | 287 | 0.130 |
Why?
|
Lithium | 1 | 2019 | 596 | 0.130 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2021 | 11709 | 0.130 |
Why?
|
Maytansine | 1 | 2015 | 86 | 0.120 |
Why?
|
Pathology | 1 | 2018 | 270 | 0.120 |
Why?
|
Inflammation Mediators | 2 | 2021 | 1879 | 0.120 |
Why?
|
Indomethacin | 1 | 1995 | 326 | 0.120 |
Why?
|
DNA-Activated Protein Kinase | 1 | 2014 | 112 | 0.120 |
Why?
|
Neoplasms | 5 | 2019 | 21986 | 0.120 |
Why?
|
Liver Cirrhosis | 2 | 2015 | 1931 | 0.120 |
Why?
|
Neutrons | 1 | 2014 | 77 | 0.110 |
Why?
|
Organ Culture Techniques | 1 | 2016 | 794 | 0.110 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2024 | 4550 | 0.110 |
Why?
|
Minocycline | 1 | 2014 | 168 | 0.110 |
Why?
|
Mesenchymal Stem Cells | 1 | 2024 | 1631 | 0.110 |
Why?
|
Lymphatic Vessels | 1 | 2018 | 358 | 0.110 |
Why?
|
Lymph Nodes | 2 | 2023 | 3470 | 0.110 |
Why?
|
Nasopharyngitis | 2 | 1991 | 10 | 0.110 |
Why?
|
Hyperalgesia | 1 | 2017 | 530 | 0.110 |
Why?
|
Antineoplastic Agents | 5 | 2017 | 13597 | 0.110 |
Why?
|
Bone Neoplasms | 1 | 2005 | 2524 | 0.110 |
Why?
|
Spinal Cord | 1 | 2021 | 1815 | 0.100 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2019 | 1016 | 0.100 |
Why?
|
Scattering, Radiation | 1 | 2014 | 488 | 0.100 |
Why?
|
Angiotensins | 1 | 2013 | 143 | 0.100 |
Why?
|
Neoplastic Stem Cells | 2 | 2024 | 1346 | 0.100 |
Why?
|
Cranial Irradiation | 1 | 2014 | 390 | 0.100 |
Why?
|
Chemokine CXCL12 | 1 | 2014 | 454 | 0.100 |
Why?
|
Intestines | 1 | 2021 | 1907 | 0.100 |
Why?
|
Benzimidazoles | 1 | 2017 | 855 | 0.100 |
Why?
|
Hearing Loss | 1 | 2019 | 781 | 0.100 |
Why?
|
Stress, Physiological | 1 | 2019 | 1399 | 0.090 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 694 | 0.090 |
Why?
|
Drug Delivery Systems | 3 | 2019 | 2211 | 0.090 |
Why?
|
Receptors, Chemokine | 1 | 2014 | 653 | 0.090 |
Why?
|
Lymphatic Metastasis | 4 | 2023 | 2914 | 0.090 |
Why?
|
Guanylate Cyclase | 1 | 2011 | 205 | 0.090 |
Why?
|
Bacteria | 1 | 2021 | 2196 | 0.090 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2014 | 607 | 0.090 |
Why?
|
Protein Kinase Inhibitors | 2 | 2017 | 5638 | 0.080 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2011 | 506 | 0.080 |
Why?
|
Female | 28 | 2024 | 389943 | 0.080 |
Why?
|
Myeloid Cells | 1 | 2014 | 820 | 0.080 |
Why?
|
Pyridines | 1 | 2020 | 2864 | 0.080 |
Why?
|
Nasopharynx | 1 | 1991 | 394 | 0.080 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2011 | 617 | 0.080 |
Why?
|
Thymus Neoplasms | 1 | 2011 | 273 | 0.080 |
Why?
|
T-Lymphocytes | 3 | 2023 | 10167 | 0.080 |
Why?
|
Lymphokines | 1 | 2011 | 926 | 0.070 |
Why?
|
Dose-Response Relationship, Radiation | 3 | 2015 | 882 | 0.070 |
Why?
|
Male | 25 | 2021 | 358180 | 0.070 |
Why?
|
Toll-Like Receptor 4 | 1 | 2011 | 576 | 0.070 |
Why?
|
Mice, Knockout | 6 | 2021 | 14345 | 0.070 |
Why?
|
Random Allocation | 3 | 2017 | 2388 | 0.070 |
Why?
|
Stromal Cells | 4 | 2016 | 1326 | 0.070 |
Why?
|
Pancreatic Neoplasms | 2 | 2016 | 5348 | 0.070 |
Why?
|
Survival Rate | 1 | 2021 | 12684 | 0.070 |
Why?
|
Longevity | 1 | 2014 | 1050 | 0.070 |
Why?
|
Spheroids, Cellular | 2 | 2019 | 329 | 0.070 |
Why?
|
Neurofibromin 2 | 2 | 2019 | 270 | 0.070 |
Why?
|
Mice, Inbred C57BL | 6 | 2021 | 21990 | 0.070 |
Why?
|
Soft Tissue Neoplasms | 1 | 1995 | 1152 | 0.070 |
Why?
|
Cytokines | 1 | 2021 | 7336 | 0.070 |
Why?
|
Mice, Transgenic | 4 | 2021 | 9514 | 0.070 |
Why?
|
Humans | 34 | 2024 | 757566 | 0.060 |
Why?
|
Nasal Mucosa | 1 | 1989 | 412 | 0.060 |
Why?
|
Nanoparticles | 1 | 2017 | 1939 | 0.060 |
Why?
|
Carbon Tetrachloride | 2 | 2015 | 72 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2017 | 3608 | 0.060 |
Why?
|
Cell Proliferation | 2 | 2017 | 10405 | 0.060 |
Why?
|
Diagnostic Imaging | 1 | 2019 | 3524 | 0.060 |
Why?
|
Colonic Neoplasms | 1 | 1996 | 2522 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 2 | 1991 | 2823 | 0.060 |
Why?
|
Brain | 4 | 2020 | 26952 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1995 | 4338 | 0.060 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2021 | 1765 | 0.050 |
Why?
|
Sarcoma, Experimental | 1 | 2003 | 117 | 0.050 |
Why?
|
Tibia | 1 | 2008 | 1065 | 0.050 |
Why?
|
Monte Carlo Method | 2 | 2020 | 1256 | 0.050 |
Why?
|
Pain | 1 | 2017 | 5063 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6840 | 0.050 |
Why?
|
Carcinoma, Renal Cell | 1 | 2016 | 3152 | 0.050 |
Why?
|
Tumor Burden | 2 | 2016 | 1886 | 0.040 |
Why?
|
Myocardial Ischemia | 1 | 2011 | 2109 | 0.040 |
Why?
|
Neuroprotective Agents | 2 | 2019 | 956 | 0.040 |
Why?
|
Inflammation | 2 | 2018 | 10709 | 0.040 |
Why?
|
Cell Survival | 3 | 2018 | 5781 | 0.040 |
Why?
|
Compressive Strength | 1 | 2020 | 157 | 0.040 |
Why?
|
Nitrosamines | 2 | 1991 | 87 | 0.040 |
Why?
|
Kidney Neoplasms | 1 | 2016 | 4220 | 0.040 |
Why?
|
Antibodies | 2 | 2019 | 2420 | 0.040 |
Why?
|
Signal Transduction | 5 | 2016 | 23335 | 0.040 |
Why?
|
Receptors, Progesterone | 1 | 2024 | 1129 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2021 | 714 | 0.040 |
Why?
|
Microscopy, Confocal | 1 | 2005 | 1966 | 0.040 |
Why?
|
Photons | 1 | 2023 | 581 | 0.040 |
Why?
|
Injections, Intraventricular | 1 | 2019 | 225 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2021 | 428 | 0.040 |
Why?
|
Specific Pathogen-Free Organisms | 2 | 1995 | 219 | 0.040 |
Why?
|
Hearing Tests | 1 | 2019 | 121 | 0.040 |
Why?
|
Liver | 1 | 2014 | 7502 | 0.040 |
Why?
|
Graft Survival | 1 | 1989 | 3794 | 0.040 |
Why?
|
Cognition | 1 | 2014 | 6952 | 0.040 |
Why?
|
Luciferases | 1 | 2019 | 714 | 0.040 |
Why?
|
Muscle Cells | 1 | 2018 | 194 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2019 | 4886 | 0.030 |
Why?
|
Pain Threshold | 1 | 2021 | 603 | 0.030 |
Why?
|
In Situ Nick-End Labeling | 1 | 2018 | 609 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1825 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2021 | 64242 | 0.030 |
Why?
|
Stereotaxic Techniques | 1 | 2019 | 549 | 0.030 |
Why?
|
Transfection | 2 | 2014 | 5777 | 0.030 |
Why?
|
Etoposide | 1 | 1998 | 634 | 0.030 |
Why?
|
Collagen | 2 | 2016 | 2634 | 0.030 |
Why?
|
Rotarod Performance Test | 1 | 2015 | 63 | 0.030 |
Why?
|
Sulfotransferases | 1 | 2016 | 149 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 1995 | 5798 | 0.030 |
Why?
|
Organoplatinum Compounds | 1 | 2017 | 406 | 0.030 |
Why?
|
Apoptosis | 4 | 2015 | 9466 | 0.030 |
Why?
|
Databases, Factual | 1 | 2011 | 7927 | 0.030 |
Why?
|
Dimethylpolysiloxanes | 1 | 2016 | 142 | 0.030 |
Why?
|
Lethal Dose 50 | 1 | 2014 | 72 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 2 | 2017 | 8143 | 0.030 |
Why?
|
Gene Expression | 2 | 2019 | 7584 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2019 | 1527 | 0.030 |
Why?
|
Indoles | 1 | 2023 | 1824 | 0.030 |
Why?
|
Hearing | 1 | 2019 | 501 | 0.030 |
Why?
|
Radiation-Protective Agents | 1 | 2014 | 88 | 0.030 |
Why?
|
Antibodies, Monoclonal | 3 | 2003 | 9163 | 0.030 |
Why?
|
Hindlimb | 1 | 1996 | 508 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2019 | 2496 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2021 | 1353 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2023 | 2295 | 0.030 |
Why?
|
Cricetinae | 1 | 1998 | 2427 | 0.030 |
Why?
|
Perfusion | 1 | 2019 | 1374 | 0.030 |
Why?
|
Obesity | 1 | 2016 | 12870 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1087 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2016 | 8512 | 0.030 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2014 | 178 | 0.030 |
Why?
|
Cell Line | 3 | 2017 | 15587 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2016 | 802 | 0.030 |
Why?
|
Lymphocytes | 1 | 2021 | 2610 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2021 | 3154 | 0.030 |
Why?
|
Cell Movement | 2 | 2016 | 5196 | 0.030 |
Why?
|
Behavior, Animal | 1 | 2021 | 1868 | 0.030 |
Why?
|
Connective Tissue Growth Factor | 1 | 2013 | 91 | 0.030 |
Why?
|
Muscular Atrophy | 1 | 2015 | 327 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2015 | 745 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2018 | 11063 | 0.030 |
Why?
|
Hepatocyte Growth Factor | 1 | 2014 | 267 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1442 | 0.030 |
Why?
|
Endothelium, Vascular | 1 | 2004 | 4427 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 3 | 1995 | 4019 | 0.030 |
Why?
|
Microscopy, Electron | 1 | 2015 | 2558 | 0.030 |
Why?
|
Sciatic Nerve | 1 | 2015 | 613 | 0.020 |
Why?
|
Polymers | 1 | 2019 | 1612 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2018 | 18936 | 0.020 |
Why?
|
Edema | 1 | 2015 | 769 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2018 | 1943 | 0.020 |
Why?
|
Oxygen | 1 | 2023 | 4190 | 0.020 |
Why?
|
Endothelin-1 | 1 | 2013 | 302 | 0.020 |
Why?
|
Rats | 3 | 2017 | 23676 | 0.020 |
Why?
|
Nitrites | 1 | 2011 | 159 | 0.020 |
Why?
|
Drug Repositioning | 1 | 2013 | 231 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2023 | 4159 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2021 | 2720 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2016 | 995 | 0.020 |
Why?
|
Blood Vessels | 1 | 2016 | 1112 | 0.020 |
Why?
|
Cell Hypoxia | 1 | 2013 | 656 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 1824 | 0.020 |
Why?
|
Nerve Regeneration | 1 | 2015 | 791 | 0.020 |
Why?
|
Cell Division | 3 | 2004 | 4459 | 0.020 |
Why?
|
Nitrates | 1 | 2011 | 263 | 0.020 |
Why?
|
Hyaluronic Acid | 1 | 2013 | 482 | 0.020 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2011 | 306 | 0.020 |
Why?
|
Skin | 1 | 2023 | 4464 | 0.020 |
Why?
|
Carcinogens | 1 | 1991 | 451 | 0.020 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2013 | 606 | 0.020 |
Why?
|
Fibrosis | 1 | 2016 | 2038 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2014 | 1788 | 0.020 |
Why?
|
Drug Synergism | 1 | 2013 | 1746 | 0.020 |
Why?
|
Cocarcinogenesis | 1 | 1988 | 49 | 0.020 |
Why?
|
Neurogenesis | 1 | 2014 | 856 | 0.020 |
Why?
|
Kinetics | 1 | 1996 | 6371 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5031 | 0.020 |
Why?
|
Growth Inhibitors | 1 | 1989 | 378 | 0.020 |
Why?
|
Equipment Design | 1 | 2016 | 3502 | 0.020 |
Why?
|
Mucous Membrane | 1 | 1991 | 657 | 0.020 |
Why?
|
DNA Damage | 1 | 1998 | 2439 | 0.020 |
Why?
|
RNA Interference | 1 | 2016 | 2834 | 0.020 |
Why?
|
Fluorouracil | 1 | 2013 | 1636 | 0.020 |
Why?
|
Biocompatible Materials | 1 | 2016 | 1686 | 0.020 |
Why?
|
Mechanotransduction, Cellular | 1 | 2013 | 530 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4845 | 0.020 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2011 | 478 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2015 | 3573 | 0.020 |
Why?
|
Plants, Medicinal | 1 | 1988 | 164 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 3432 | 0.020 |
Why?
|
Neuroblastoma | 1 | 1995 | 1247 | 0.020 |
Why?
|
Pain Measurement | 1 | 2017 | 3523 | 0.020 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2011 | 580 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 2469 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2014 | 9245 | 0.020 |
Why?
|
Fibroblasts | 1 | 2016 | 4087 | 0.020 |
Why?
|
Carcinoma in Situ | 1 | 1991 | 793 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1995 | 6525 | 0.020 |
Why?
|
Benzamides | 1 | 2011 | 1363 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6470 | 0.020 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2016 | 1723 | 0.020 |
Why?
|
Body Weight | 1 | 1995 | 4602 | 0.010 |
Why?
|
Doxorubicin | 1 | 2011 | 2211 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2016 | 3298 | 0.010 |
Why?
|
Carcinoma | 1 | 1995 | 2330 | 0.010 |
Why?
|
Cause of Death | 1 | 2014 | 3667 | 0.010 |
Why?
|
Neutrophils | 1 | 2016 | 3756 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9624 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2011 | 2203 | 0.010 |
Why?
|
Transplantation, Isogeneic | 1 | 2003 | 248 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2020 | 20037 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7399 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4492 | 0.010 |
Why?
|
Macrophages | 1 | 2016 | 5732 | 0.010 |
Why?
|
Piperazines | 1 | 2011 | 2511 | 0.010 |
Why?
|
Models, Biological | 1 | 2016 | 9459 | 0.010 |
Why?
|
Radiation Dosage | 1 | 2008 | 1957 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9403 | 0.010 |
Why?
|
Neurons | 1 | 2019 | 9418 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13463 | 0.010 |
Why?
|
Pyrimidines | 1 | 2011 | 3005 | 0.010 |
Why?
|
Phenotype | 1 | 2016 | 16533 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 54092 | 0.010 |
Why?
|
Body Mass Index | 1 | 2016 | 12868 | 0.010 |
Why?
|
Echocardiography | 1 | 2011 | 4963 | 0.010 |
Why?
|
Electrocardiography | 1 | 2011 | 6363 | 0.010 |
Why?
|
Time Factors | 2 | 1996 | 39811 | 0.010 |
Why?
|
Age Factors | 1 | 2014 | 18326 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2013 | 8503 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17767 | 0.010 |
Why?
|
Chronic Disease | 1 | 1989 | 9263 | 0.010 |
Why?
|
HeLa Cells | 2 | 1990 | 3096 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14637 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2011 | 11422 | 0.010 |
Why?
|
Carcinogenicity Tests | 1 | 1989 | 38 | 0.010 |
Why?
|
Spleen | 1 | 1989 | 2295 | 0.000 |
Why?
|
Adolescent | 1 | 1989 | 87819 | 0.000 |
Why?
|
Middle Aged | 1 | 1989 | 219192 | 0.000 |
Why?
|
Adult | 1 | 1989 | 219725 | 0.000 |
Why?
|